Press Releases

C-Reactive Protein Testing Market Trends and Key Players

C-Reactive Protein Testing Market Key Companies, Trends, and Growth Outlook

The global market for C-reactive protein (CRP) testing is valued at approximately USD 5.58 billion in 2024, with a slight increase to USD 5.6 billion in 2025. By 2034, the market is expected to reach around USD 5.75 billion, growing at a modest annual rate of 0.3% from 2024 to 2034. Factors driving this growth include the rising prevalence of both acute and chronic inflammatory conditions, advancements in testing technologies, and an increasing demand for point-of-care diagnostic solutions.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5347

C-Reactive Protein Testing Market Trends

  1. Rising Prevalence of Inflammatory Diseases: With an increase in both acute and chronic inflammatory conditions such as cardiovascular diseases, autoimmune disorders, and infections, the demand for C-reactive protein (CRP) testing is steadily growing. CRP testing plays a key role in diagnosing and monitoring inflammation in the body.
  2. Technological Advancements: Innovations in CRP testing technologies, such as high-sensitivity CRP tests, are improving accuracy and enabling earlier detection of inflammation-related health issues. These advancements are driving the adoption of CRP tests in both clinical and point-of-care settings.
  3. Growth in Point-of-Care Testing: There is a significant shift toward point-of-care testing, where CRP tests can be performed outside traditional laboratory settings. This trend is gaining momentum due to the need for faster results, particularly in emergency care and primary care environments.
  4. Rising Demand for Preventative Healthcare: As healthcare systems move towards preventive care, CRP testing is increasingly used to assess patients’ risk for chronic conditions, such as heart disease. Regular monitoring of CRP levels helps in early risk detection and management.
  5. Growing Healthcare Awareness: Increased awareness among patients and healthcare professionals about the role of CRP testing in monitoring inflammation has led to a higher uptake of testing, further fueling market growth.
  6. Shift Towards Home-based Testing: The convenience of home-based testing kits for CRP is gaining popularity, particularly among individuals with chronic conditions who require regular monitoring. These at-home tests offer convenience, privacy, and reduced healthcare costs.
  7. Expanding Clinical Applications: CRP testing is expanding its clinical use beyond traditional inflammation monitoring to assessing disease progression and response to treatments, further broadening its market appeal.

Top Companies in the C-Reactive Protein Testing Market

  • Abbott Laboratories
    Abbott is a global healthcare leader, known for its diagnostic solutions. The company offers a wide range of CRP testing kits, including high-sensitivity CRP (hs-CRP) tests. Abbott’s diagnostic systems are used in various healthcare settings, such as hospitals, labs, and point-of-care environments.
  • Beckman Coulter
    Beckman Coulter, part of Danaher Corporation, provides laboratory instruments, reagents, and consumables, including those for CRP testing. Their solutions are designed for fast, accurate diagnostics and are widely used in clinical laboratories worldwide.
  • Boditech Med, Inc.
    A leader in point-of-care diagnostics, Boditech Med specializes in diagnostic solutions, including CRP tests. Their innovative technology allows for rapid, on-site testing, contributing to the growing trend of point-of-care diagnostics.
  • Danaher Corporation
    Danaher, a global conglomerate, owns several healthcare brands that produce diagnostic products. Their CRP testing offerings are part of their broad portfolio, supporting hospitals, labs, and point-of-care settings with advanced diagnostic solutions.
  • F. Hoffmann-La Roche
    Roche is a key player in the diagnostic market and offers high-quality CRP testing products. Their diagnostics division includes both laboratory and point-of-care solutions, with a focus on improving patient care and outcomes.
  • Horiba, Ltd.
    A multinational corporation, Horiba provides a variety of analytical instruments, including CRP testing systems. Their products are used for healthcare diagnostics in laboratories and point-of-care settings globally.
  • LabCorp Holdings, Inc.
    LabCorp is one of the largest clinical laboratory networks in the U.S. The company provides CRP testing services and uses advanced diagnostic technologies to help healthcare providers detect and manage inflammation-related conditions.
  • Merck
    Merck offers a range of diagnostic tools, including tests for CRP levels. Their focus on improving health outcomes through innovative testing products has contributed to their strong position in the market.
  • Ortho Clinical Diagnostics
    Specializing in in vitro diagnostics, Ortho Clinical Diagnostics provides CRP testing solutions that are widely used in clinical laboratories. The company focuses on offering high-quality diagnostic tests for accurate, timely results.
  • Quest Diagnostics
    As a leading provider of diagnostic testing services in the U.S., Quest Diagnostics offers CRP testing as part of its comprehensive lab services. The company plays a vital role in helping healthcare providers monitor inflammation and chronic diseases.
  • Randox Laboratories
    Randox is a global leader in diagnostic reagents and testing systems, including CRP tests. Their high-sensitivity CRP testing solutions are widely used in clinical and point-of-care environments.
  • Siemens Healthcare Pvt. Ltd.
    Siemens Healthcare provides diagnostic solutions that include CRP testing kits. The company is known for its high-precision instruments used in clinical laboratories and hospitals worldwide.
  • Thermo Fisher Scientific
    Thermo Fisher is a major provider of laboratory equipment, reagents, and diagnostics, including CRP tests. Their products are widely used in clinical settings for inflammation and disease monitoring.
  • Trinity Biotech
    Trinity Biotech specializes in developing and manufacturing diagnostic products, including tests for CRP. Their solutions cater to both laboratory and point-of-care markets, offering convenience and accuracy.
  • Zoetis
    Zoetis is a leader in animal health diagnostics and offers CRP testing solutions primarily for veterinary use. Their products help in diagnosing inflammation and monitoring health conditions in animals.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions:  https://www.towardshealthcare.com/table-of-content/c-reactive-protein-testing-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5347

We’ve prepared a service to support you. Please feel free to contact us at  sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Raj Dombe

Recent Posts

Vein Finder Market Recent Innovations and Key Players (2024 – 2032)

Vein Finder Market Growth and Forecast (2024 - 2032) The global vein finder market is projected to expand from USD… Read More

2 days ago

Bone Densitometer Market Analysis Growth, Trends and Future Outlook

Bone Densitometer Market Overview Growth, Trends and Future Projections The global bone densitometer market was valued at USD 308.33 million… Read More

2 days ago

Market Analysis Autoimmune Hepatitis Diagnosis and Treatment Trends

Global Market for Autoimmune Hepatitis Diagnosis and Treatment Projected Growth and Trends The global market for autoimmune hepatitis diagnosis and… Read More

2 days ago

Hemato-Oncology Testing Market Insights 2024-2033

Hemato-Oncology Testing Market Growth and Key Players The global hemato-oncology testing market was valued at $3.17 billion in 2023 and… Read More

2 days ago

Synovial Sarcoma Treatment Market Outlook (2023 – 2033)

Synovial Sarcoma Treatment Market Insights The synovial sarcoma treatment market was valued at USD 822.74 million in 2023 and is… Read More

2 days ago

Chronic Lower Back Pain Market Overview

Chronic Lower Back Pain Market Growth, Future Trends and Forecast The chronic lower back pain market was valued at $2.46… Read More

3 days ago